Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-103174·INTEGRATED CORE STRATEGIES (US) LLC
Schedule 13G ownership disclosure
Nektar Therapeutics
Common Stock, par value $0.0001 per share · CUSIP: 640268306
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Integrated Core Strategies (US) LLC
Shares: 333,576.00 · Class: 1.8%
- Millennium Management LLC
Shares: 570,994.00 · Class: 3.0%
- Millennium Group Management LLC
Shares: 570,994.00 · Class: 3.0%
- Israel A. Englander
Shares: 570,994.00 · Class: 3.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-103174
- Form type
- SCHEDULE 13G/A
- Filer
- INTEGRATED CORE STRATEGIES (US) LLC
- CIK
- CIK 1319244
- Filed
- Oct 28, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership